A certain drug can be used to reduce the acid produced by the body and heal damage to the esophagus due to acid reflux. The manufacturer of the drug claims that more than $94\%$ of patients taking the drug are healed within $8$ weeks. In clinical$$ trials, $226$ of $238$ patients suffering from acid reflux disease were healed after $8$ weeks. Test the$$ manufacturer's claim at the alpha$=0\mathrm{.}01$ level of signific Choose the correct conclusion below.

A$.$

Reject the null hypothesis. There is insufficient evidence to conclude that more than $94\%$ of patients taking the drug are healed within $8$ weeks.

B$.$

Do not reject the null hypothesis. There is insufficient evidence to conclude that more than $94\%$ of patients taking the drug are healed within $8$ weeks.

C$.$

Do not reject the null hypothesis. There is sufficient evidence to conclude more than $94\%$ of patients taking the drug are healed within $8$ weeks.

D$.$

reject the null hypothesis. There is sufficient evidence to conclude that more than $94\%$ of patients taking the drug are healed within $8$ weeks.